Bringing the fundamentals into focus…
Back to Takeda Pharmaceutical Company Limited
How Takeda Pharmaceutical Company Limited stacks up
TAK · against 54 other Healthcare companies of similar size
Overall
30/ 100
Near the bottom of its peers.
Ranked #53 of 55 · scores higher than 4% of peers
Bars: peers in each 10-point band of the overall score3 peers with an overall score of 30–39, including TAK · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around TAK| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 56.7B USD | 79 | 42 | 96 | 93 | 0 / 2 | |
| 2 | 534.1B HKD (≈$68.4B) | 75 | 72 | 76 | 96 | 1 / 2 | |
| 2 | 327.3B CNY (≈$45.8B) | 75 | 49 | 64 | 96 | 0 / 2 | |
| 2 | 8.24T JPY (≈$56.0B) | 75 | 57 | 63 | 98 | 0 / 2 | |
| 5 | 40.2B USD | 73 | 46 | 92 | 93 | 1 / 2 | |
| 49 | 43.2B USD | 45 | 60 | 50 | 66 | 2 / 2 | |
| 50 | 272.9B BRL (≈$49.1B) | 43 | 54 | 44 | 67 | 2 / 2 | |
| 51 | 56.0B USD | 39 | 8 | 86 | 26 | 1 / 2 | |
| 52 | 41.6B USD | 34 | 8 | — | 14 | 0 / 2 | |
| 53 | 66.3B USD | 30 | 44 | 20 | 37 | 2 / 2 | |
| 54 | 33.3B USD | 24 | 8 | 43 | 27 | 2 / 2 | |
| 55 | 91.2B USD | 18 | 8 | 5 | 14 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score